ArticleCureus2026
Libman-Sacks Endocarditis As the Initial Presentation of Systemic Lupus Erythematosus With Evolving Multiorgan Sequelae.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Libman-Sacks endocarditis (LSE) is a rare non-bacterial thrombotic endocarditis (NBTE) characterised by sterile valvular vegetations. It is most associated with systemic lupus erythematosus (SLE) and is often asymptomatic until embolic complications occur, rendering diagnosis challenging. This report presents the case of a 53-year-old woman initially presenting with abdominal pain secondary to pancreatitis and persistent fevers of unknown origin. Despite extensive investigation, including multiple negative blood cultures, no infectious source was identified. Subsequent transthoracic echocardiography demonstrated a valvular vegetation suggestive of endocarditis, with further assessment producing a clinical diagnosis of the rare LSE subtype. Notably, the patient had no peripheral stigmata of endocarditis, and LSE represented the first manifestation of previously undiagnosed SLE in the context of an underlying connective tissue disorder. During the hospital course, the patient developed additional manifestations of SLE, including cutaneous lupus erythematosus and lupus nephritis. Autoimmune serology was strongly supportive of SLE. Treatment consisted of corticosteroids, hydroxychloroquine and mycophenolate mofetil, resulting in clinical improvement. This case is notable as LSE being a first presentation of previously undiagnosed SLE. It highlights the importance of having high suspicion for LSE in patients with culture-negative endocarditis, persistent unexplained fever, and a background of autoimmune disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.